Tempered Networks Partners with NTT Advanced Technology Corporation
Feb 07, 2018 12:01 pm UTC| Business
SEATTLE, Feb. 07, 2018 -- Tempered Networks, Inc., the pioneer of Identity-Defined Networking (IDN), today announced that NTT Advanced Technology Corporation (NTT-AT) has agreed to resell Tempered Networks’...
Feb 07, 2018 12:01 pm UTC| Business
PORTLAND, Ore., Feb. 07, 2018 -- Aunt Fannie’s, creating healthy homes, restoring the biome we live in, recharging our immunity and strengthening our families with natural, healthy household cleaning products and pest...
Feb 07, 2018 12:01 pm UTC| Business
Geneva, Switzerland and Boston, MA - February 7, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions...
LGI Homes Introduces Townhomes in Nashville Market
Feb 07, 2018 12:01 pm UTC| Business
NASHVILLE, Tenn., Feb. 07, 2018 -- LGI Homes, Inc. (Nasdaq:LGIH) introduces its first townhome product and fourth community in the Nashville market. Located in La Vergne, The Cottages of Lake Forest offers close...
Another Fortune 500 Company to Conduct Pilot Evaluation of OneSoft’s Machine Learning Platform
Feb 07, 2018 12:01 pm UTC| Business
Edmonton, Alberta, Feb. 07, 2018 -- OneSoft Solutions Inc. (the “Company” or “OneSoft”) (TSX-V:OSS, OTC:OSSIF) is pleased to announce that its wholly owned subsidiary, OneBridge Solutions, Inc. (“OneBridge”), has...
Funko Announces Date of Fourth Quarter and Fiscal Year 2017 Earnings Conference Call
Feb 07, 2018 12:01 pm UTC| Business
EVERETT, Wash., Feb. 07, 2018 -- Funko, Inc. (Nasdaq:FNKO), a leading pop culture consumer products company, today announced that its financial results for the fourth quarter and fiscal year 2017 will be released after...
Humanigen Appoints Rainer Boehm, M.D., to Board of Directors
Feb 07, 2018 12:00 pm UTC| Business
BRISBANE, Calif., Feb. 07, 2018 -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments,...